A potent and selective CB1 receptor agonist (Kis = 5.6 and >1,000 nM for CB1 and CB2, respectively); induces lipolysis, reduces hepatomegaly, decreases body weight, and improves dyslipidemia by reducing triglyceride, free fatty acid, and total cholesterol levels and by increasing HDL/LDL ratios in rodent models; elicits antiproliferative and immunomodulatory effects in vitro,